| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sequence Analysis, DNA | 30 | 2020 | 4803 | 3.110 |
Why?
|
| Genome, Human | 35 | 2023 | 4420 | 2.980 |
Why?
|
| DNA Copy Number Variations | 17 | 2021 | 1941 | 2.320 |
Why?
|
| Chromatin Immunoprecipitation | 22 | 2015 | 893 | 2.240 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 32 | 2012 | 3920 | 2.220 |
Why?
|
| Chromatin | 40 | 2024 | 2934 | 2.180 |
Why?
|
| Software | 20 | 2022 | 4443 | 2.110 |
Why?
|
| Dosage Compensation, Genetic | 15 | 2014 | 211 | 2.110 |
Why?
|
| Genomics | 28 | 2023 | 5720 | 1.880 |
Why?
|
| Drosophila melanogaster | 31 | 2017 | 1708 | 1.830 |
Why?
|
| High-Throughput Nucleotide Sequencing | 21 | 2022 | 3597 | 1.820 |
Why?
|
| Gene Expression Profiling | 42 | 2017 | 9438 | 1.820 |
Why?
|
| Nucleosomes | 16 | 2021 | 494 | 1.810 |
Why?
|
| Chromosomes | 7 | 2022 | 596 | 1.710 |
Why?
|
| X Chromosome | 18 | 2017 | 814 | 1.710 |
Why?
|
| Drosophila Proteins | 26 | 2017 | 1703 | 1.560 |
Why?
|
| Genome | 14 | 2023 | 1808 | 1.530 |
Why?
|
| Histones | 32 | 2023 | 2599 | 1.520 |
Why?
|
| Neoplasms | 39 | 2024 | 21683 | 1.500 |
Why?
|
| Databases, Genetic | 13 | 2021 | 1783 | 1.460 |
Why?
|
| Mutation | 49 | 2024 | 29786 | 1.400 |
Why?
|
| DNA Transposable Elements | 4 | 2021 | 748 | 1.360 |
Why?
|
| Single-Cell Analysis | 16 | 2022 | 2183 | 1.310 |
Why?
|
| Models, Genetic | 14 | 2019 | 3494 | 1.260 |
Why?
|
| Microsatellite Instability | 5 | 2018 | 684 | 1.260 |
Why?
|
| Retroelements | 4 | 2023 | 164 | 1.230 |
Why?
|
| Algorithms | 28 | 2019 | 13881 | 1.120 |
Why?
|
| Translocation, Genetic | 3 | 2023 | 1420 | 1.090 |
Why?
|
| Chromosome Mapping | 12 | 2021 | 4740 | 1.080 |
Why?
|
| INDEL Mutation | 3 | 2024 | 279 | 1.060 |
Why?
|
| Computational Biology | 24 | 2021 | 3521 | 1.020 |
Why?
|
| Molecular Sequence Annotation | 8 | 2021 | 528 | 0.980 |
Why?
|
| Gene Dosage | 9 | 2019 | 1252 | 0.950 |
Why?
|
| Transcription, Genetic | 24 | 2021 | 7722 | 0.880 |
Why?
|
| Gene Amplification | 3 | 2023 | 1063 | 0.880 |
Why?
|
| Oncogene Fusion | 2 | 2020 | 99 | 0.870 |
Why?
|
| Gene Rearrangement | 5 | 2021 | 1179 | 0.860 |
Why?
|
| Gene Expression Regulation, Neoplastic | 19 | 2021 | 8428 | 0.840 |
Why?
|
| Oncogenes | 4 | 2023 | 1265 | 0.820 |
Why?
|
| Transcription Factors | 34 | 2021 | 12208 | 0.820 |
Why?
|
| Mutagenesis, Insertional | 3 | 2021 | 655 | 0.810 |
Why?
|
| Chromosome Aberrations | 7 | 2023 | 1813 | 0.780 |
Why?
|
| Music | 1 | 2024 | 263 | 0.750 |
Why?
|
| Allelic Imbalance | 2 | 2023 | 77 | 0.740 |
Why?
|
| DNA, Intergenic | 1 | 2020 | 107 | 0.710 |
Why?
|
| Cell Nucleus | 4 | 2023 | 2969 | 0.710 |
Why?
|
| Promoter Regions, Genetic | 20 | 2019 | 5867 | 0.700 |
Why?
|
| Uterine Artery Embolization | 1 | 2020 | 62 | 0.690 |
Why?
|
| Sequence Analysis, RNA | 8 | 2022 | 2012 | 0.690 |
Why?
|
| Nuclear Proteins | 21 | 2017 | 5853 | 0.680 |
Why?
|
| Chromatin Assembly and Disassembly | 9 | 2019 | 635 | 0.680 |
Why?
|
| Estrogen Receptor alpha | 1 | 2023 | 577 | 0.670 |
Why?
|
| DNA, Neoplasm | 4 | 2019 | 1758 | 0.670 |
Why?
|
| Gene Expression Regulation | 30 | 2021 | 12072 | 0.660 |
Why?
|
| Exons | 7 | 2023 | 2437 | 0.650 |
Why?
|
| Leiomyoma | 4 | 2020 | 730 | 0.630 |
Why?
|
| Genes, X-Linked | 4 | 2013 | 128 | 0.630 |
Why?
|
| Base Sequence | 16 | 2020 | 12797 | 0.630 |
Why?
|
| Sequence Alignment | 4 | 2008 | 2256 | 0.620 |
Why?
|
| Workflow | 3 | 2021 | 847 | 0.610 |
Why?
|
| Long Interspersed Nucleotide Elements | 6 | 2020 | 338 | 0.610 |
Why?
|
| Gene Fusion | 2 | 2022 | 371 | 0.610 |
Why?
|
| Femoral Vein | 1 | 2018 | 159 | 0.600 |
Why?
|
| Epigenesis, Genetic | 16 | 2024 | 3647 | 0.590 |
Why?
|
| Point Mutation | 1 | 2022 | 1623 | 0.580 |
Why?
|
| Jugular Veins | 1 | 2018 | 204 | 0.580 |
Why?
|
| Colorectal Neoplasms | 7 | 2024 | 6773 | 0.580 |
Why?
|
| DNA-Binding Proteins | 22 | 2021 | 9648 | 0.550 |
Why?
|
| Rhabdoid Tumor | 5 | 2019 | 212 | 0.550 |
Why?
|
| Chromosomal Proteins, Non-Histone | 7 | 2017 | 736 | 0.550 |
Why?
|
| Polymorphism, Single Nucleotide | 15 | 2022 | 15519 | 0.550 |
Why?
|
| User-Computer Interface | 8 | 2021 | 1431 | 0.540 |
Why?
|
| Humans | 189 | 2024 | 744343 | 0.530 |
Why?
|
| Genome, Insect | 6 | 2017 | 102 | 0.530 |
Why?
|
| Morphine | 1 | 2020 | 657 | 0.520 |
Why?
|
| Genomic Instability | 3 | 2021 | 695 | 0.520 |
Why?
|
| Enhancer Elements, Genetic | 9 | 2019 | 1341 | 0.510 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2017 | 2942 | 0.510 |
Why?
|
| Mosaicism | 6 | 2023 | 441 | 0.510 |
Why?
|
| Quality Control | 6 | 2022 | 841 | 0.500 |
Why?
|
| Comparative Genomic Hybridization | 4 | 2012 | 496 | 0.500 |
Why?
|
| Histone Chaperones | 3 | 2021 | 76 | 0.490 |
Why?
|
| Homeodomain Proteins | 7 | 2020 | 2421 | 0.490 |
Why?
|
| Uterine Neoplasms | 4 | 2020 | 1513 | 0.480 |
Why?
|
| Catheterization, Peripheral | 1 | 2018 | 345 | 0.480 |
Why?
|
| Animals | 112 | 2024 | 168757 | 0.480 |
Why?
|
| RNA | 5 | 2022 | 2749 | 0.470 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 2015 | 794 | 0.470 |
Why?
|
| Gene Regulatory Networks | 6 | 2021 | 1708 | 0.460 |
Why?
|
| Regulatory Elements, Transcriptional | 3 | 2013 | 186 | 0.460 |
Why?
|
| DNA Polymerase II | 2 | 2013 | 107 | 0.460 |
Why?
|
| DNA Mutational Analysis | 10 | 2020 | 4186 | 0.450 |
Why?
|
| Nerve Block | 1 | 2020 | 644 | 0.450 |
Why?
|
| Drosophila | 5 | 2015 | 1491 | 0.450 |
Why?
|
| Catheterization, Central Venous | 1 | 2018 | 514 | 0.450 |
Why?
|
| Encyclopedias as Topic | 1 | 2012 | 20 | 0.440 |
Why?
|
| Glioblastoma | 10 | 2019 | 3481 | 0.430 |
Why?
|
| Saccharomyces cerevisiae Proteins | 5 | 2021 | 1888 | 0.420 |
Why?
|
| Heterochromatin | 5 | 2017 | 296 | 0.420 |
Why?
|
| Genome, Fungal | 4 | 2017 | 204 | 0.420 |
Why?
|
| Embryonic Stem Cells | 10 | 2017 | 1294 | 0.420 |
Why?
|
| Genetic Variation | 9 | 2021 | 6544 | 0.410 |
Why?
|
| Internet | 6 | 2020 | 3064 | 0.410 |
Why?
|
| Pluripotent Stem Cells | 5 | 2018 | 795 | 0.400 |
Why?
|
| Genes, Homeobox | 3 | 2013 | 286 | 0.400 |
Why?
|
| Neurofibrosarcoma | 2 | 2023 | 24 | 0.400 |
Why?
|
| Hydrocephalus, Normal Pressure | 2 | 2023 | 92 | 0.400 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 4 | 2020 | 798 | 0.390 |
Why?
|
| Gene Expression Regulation, Developmental | 11 | 2021 | 3617 | 0.390 |
Why?
|
| Nucleic Acid Hybridization | 5 | 2015 | 1375 | 0.380 |
Why?
|
| Patient Preference | 1 | 2018 | 890 | 0.370 |
Why?
|
| Smegmamorpha | 1 | 2010 | 21 | 0.370 |
Why?
|
| Protein Isoforms | 1 | 2015 | 1730 | 0.370 |
Why?
|
| Social Welfare | 1 | 2011 | 87 | 0.360 |
Why?
|
| Neurons | 11 | 2024 | 9338 | 0.360 |
Why?
|
| Organ Specificity | 5 | 2023 | 2008 | 0.360 |
Why?
|
| Caenorhabditis elegans | 4 | 2014 | 1419 | 0.350 |
Why?
|
| Work | 1 | 2011 | 191 | 0.350 |
Why?
|
| Transcriptional Elongation Factors | 3 | 2021 | 166 | 0.350 |
Why?
|
| Anemia, Sickle Cell | 1 | 2018 | 1018 | 0.350 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 1643 | 0.350 |
Why?
|
| Ecology | 1 | 2010 | 106 | 0.350 |
Why?
|
| Telencephalon | 1 | 2010 | 142 | 0.350 |
Why?
|
| Genes, Neoplasm | 4 | 2019 | 376 | 0.340 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2012 | 436 | 0.340 |
Why?
|
| DNA Probes | 4 | 2008 | 560 | 0.330 |
Why?
|
| Base Composition | 3 | 2016 | 293 | 0.320 |
Why?
|
| Vascular Endothelial Growth Factor A | 6 | 2019 | 3508 | 0.320 |
Why?
|
| Cell Lineage | 6 | 2021 | 2504 | 0.310 |
Why?
|
| RNA Polymerase II | 6 | 2017 | 551 | 0.310 |
Why?
|
| Programming Languages | 2 | 2021 | 133 | 0.300 |
Why?
|
| Binding Sites | 13 | 2021 | 6114 | 0.300 |
Why?
|
| RNA Splicing | 5 | 2023 | 907 | 0.300 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 4042 | 0.300 |
Why?
|
| Endometrial Neoplasms | 2 | 2013 | 1353 | 0.300 |
Why?
|
| RNA, Messenger | 11 | 2019 | 13033 | 0.290 |
Why?
|
| Genomic Structural Variation | 2 | 2019 | 64 | 0.290 |
Why?
|
| Sequence Analysis | 2 | 2022 | 256 | 0.290 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2009 | 2649 | 0.280 |
Why?
|
| Neurofibromatosis 1 | 2 | 2023 | 569 | 0.280 |
Why?
|
| Vitamin A | 1 | 2009 | 615 | 0.280 |
Why?
|
| Ovarian Neoplasms | 6 | 2022 | 4838 | 0.270 |
Why?
|
| Neural Stem Cells | 5 | 2021 | 851 | 0.270 |
Why?
|
| RNA-Binding Proteins | 6 | 2020 | 1903 | 0.270 |
Why?
|
| Mice | 52 | 2023 | 81183 | 0.270 |
Why?
|
| Saccharomyces cerevisiae | 6 | 2021 | 2752 | 0.270 |
Why?
|
| DNA Methylation | 11 | 2023 | 4286 | 0.260 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2015 | 1736 | 0.260 |
Why?
|
| Brain Neoplasms | 8 | 2024 | 8863 | 0.260 |
Why?
|
| Disease Progression | 6 | 2019 | 13284 | 0.260 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 2019 | 1581 | 0.260 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2021 | 17446 | 0.260 |
Why?
|
| Gene Frequency | 4 | 2021 | 3588 | 0.260 |
Why?
|
| DNA | 6 | 2023 | 7301 | 0.250 |
Why?
|
| Astrocytoma | 1 | 2009 | 790 | 0.250 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2016 | 3143 | 0.250 |
Why?
|
| Cell Line, Tumor | 18 | 2019 | 16689 | 0.250 |
Why?
|
| Cell Line | 19 | 2021 | 15997 | 0.240 |
Why?
|
| Nerve Tissue Proteins | 6 | 2020 | 4462 | 0.240 |
Why?
|
| Mice, Nude | 8 | 2019 | 3689 | 0.240 |
Why?
|
| Introns | 3 | 2023 | 991 | 0.240 |
Why?
|
| Schizosaccharomyces pombe Proteins | 2 | 2017 | 178 | 0.240 |
Why?
|
| Research Design | 3 | 2008 | 5987 | 0.240 |
Why?
|
| Databases, Protein | 1 | 2006 | 383 | 0.240 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2023 | 40 | 0.240 |
Why?
|
| MicroRNAs | 8 | 2019 | 3752 | 0.240 |
Why?
|
| Genetic Heterogeneity | 3 | 2020 | 733 | 0.240 |
Why?
|
| Centromere | 2 | 2015 | 220 | 0.240 |
Why?
|
| Acetylation | 7 | 2017 | 1085 | 0.240 |
Why?
|
| Podocytes | 2 | 2020 | 396 | 0.230 |
Why?
|
| Genes, Developmental | 2 | 2017 | 40 | 0.230 |
Why?
|
| Prosencephalon | 2 | 2021 | 303 | 0.230 |
Why?
|
| Cluster Analysis | 10 | 2015 | 2715 | 0.230 |
Why?
|
| Computer Simulation | 6 | 2019 | 6196 | 0.230 |
Why?
|
| Cell Differentiation | 11 | 2021 | 11483 | 0.230 |
Why?
|
| Alu Elements | 1 | 2023 | 119 | 0.230 |
Why?
|
| Schizosaccharomyces | 2 | 2017 | 237 | 0.220 |
Why?
|
| Mouth Neoplasms | 3 | 2003 | 601 | 0.220 |
Why?
|
| Minisatellite Repeats | 1 | 2023 | 165 | 0.220 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2022 | 2948 | 0.220 |
Why?
|
| Tooth Diseases | 1 | 2003 | 77 | 0.220 |
Why?
|
| Protein Processing, Post-Translational | 7 | 2017 | 1990 | 0.220 |
Why?
|
| Ataxia Telangiectasia | 1 | 2023 | 112 | 0.210 |
Why?
|
| Genes, Insect | 5 | 2011 | 268 | 0.210 |
Why?
|
| Chromosome Breakpoints | 2 | 2020 | 98 | 0.210 |
Why?
|
| Information Storage and Retrieval | 4 | 2013 | 824 | 0.210 |
Why?
|
| Neurogenesis | 2 | 2020 | 838 | 0.210 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2004 | 323 | 0.210 |
Why?
|
| Bayes Theorem | 3 | 2016 | 2309 | 0.210 |
Why?
|
| Parathyroid Glands | 1 | 2024 | 509 | 0.210 |
Why?
|
| DNA Repair | 4 | 2023 | 2046 | 0.210 |
Why?
|
| Equipment Failure Analysis | 1 | 2004 | 868 | 0.200 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 1 | 2021 | 9 | 0.200 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2022 | 248 | 0.200 |
Why?
|
| Proteome | 2 | 2014 | 1799 | 0.200 |
Why?
|
| Nucleotides | 2 | 2022 | 464 | 0.200 |
Why?
|
| Pseudogenes | 1 | 2021 | 113 | 0.200 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2013 | 670 | 0.200 |
Why?
|
| Male | 64 | 2024 | 350118 | 0.200 |
Why?
|
| Female | 60 | 2023 | 380194 | 0.200 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2024 | 241 | 0.200 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2023 | 433 | 0.200 |
Why?
|
| Otx Transcription Factors | 1 | 2021 | 43 | 0.200 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2023 | 190 | 0.200 |
Why?
|
| Gastrulation | 1 | 2021 | 32 | 0.200 |
Why?
|
| Chromosomes, Insect | 2 | 2011 | 15 | 0.200 |
Why?
|
| Genes, Neurofibromatosis 2 | 2 | 2012 | 124 | 0.190 |
Why?
|
| Genotype | 8 | 2021 | 12951 | 0.190 |
Why?
|
| Oxidoreductases, N-Demethylating | 2 | 2013 | 115 | 0.190 |
Why?
|
| Alternative Splicing | 3 | 2020 | 1117 | 0.190 |
Why?
|
| Deoxyribonuclease I | 2 | 2012 | 229 | 0.190 |
Why?
|
| Mouth Diseases | 1 | 2003 | 241 | 0.190 |
Why?
|
| HeLa Cells | 4 | 2012 | 3128 | 0.190 |
Why?
|
| Neoplasm Proteins | 2 | 2016 | 3703 | 0.190 |
Why?
|
| Multigene Family | 4 | 2013 | 1102 | 0.190 |
Why?
|
| Data Interpretation, Statistical | 3 | 2014 | 2716 | 0.180 |
Why?
|
| DNA Damage | 6 | 2023 | 2432 | 0.180 |
Why?
|
| Gene Deletion | 3 | 2015 | 2751 | 0.180 |
Why?
|
| Cell Proliferation | 10 | 2021 | 10481 | 0.180 |
Why?
|
| Breast Neoplasms | 4 | 2023 | 20822 | 0.180 |
Why?
|
| Reproducibility of Results | 14 | 2021 | 19905 | 0.180 |
Why?
|
| Molecular Conformation | 1 | 2021 | 563 | 0.180 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2021 | 124 | 0.180 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2019 | 4554 | 0.180 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2021 | 177 | 0.180 |
Why?
|
| Genome-Wide Association Study | 7 | 2017 | 12261 | 0.180 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2022 | 2938 | 0.180 |
Why?
|
| Sex Chromosomes | 2 | 2013 | 105 | 0.180 |
Why?
|
| Cerebral Cortex | 4 | 2020 | 5708 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2017 | 2503 | 0.170 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2020 | 109 | 0.170 |
Why?
|
| Brain Chemistry | 2 | 2021 | 981 | 0.170 |
Why?
|
| Dissection | 1 | 2021 | 295 | 0.170 |
Why?
|
| Leiomyosarcoma | 1 | 2023 | 477 | 0.170 |
Why?
|
| RNA, Antisense | 2 | 2017 | 138 | 0.170 |
Why?
|
| Cells, Cultured | 13 | 2021 | 19229 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2020 | 3557 | 0.170 |
Why?
|
| Germ Cells | 3 | 2021 | 631 | 0.170 |
Why?
|
| Poverty | 1 | 2011 | 2660 | 0.170 |
Why?
|
| Platinum Compounds | 1 | 2019 | 96 | 0.160 |
Why?
|
| Lysine | 4 | 2017 | 1007 | 0.160 |
Why?
|
| Neurofibromin 1 | 1 | 2020 | 196 | 0.160 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2023 | 594 | 0.160 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 142 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 234 | 0.160 |
Why?
|
| Protein Binding | 11 | 2017 | 9386 | 0.160 |
Why?
|
| Histone Code | 2 | 2020 | 163 | 0.160 |
Why?
|
| Dermatomyositis | 3 | 2005 | 224 | 0.160 |
Why?
|
| Sarcoma | 4 | 2012 | 1897 | 0.160 |
Why?
|
| Repressor Proteins | 4 | 2015 | 3023 | 0.160 |
Why?
|
| Glioma | 4 | 2020 | 3401 | 0.160 |
Why?
|
| Physical Exertion | 1 | 2021 | 695 | 0.160 |
Why?
|
| Germ-Line Mutation | 3 | 2021 | 1788 | 0.160 |
Why?
|
| Databases, Nucleic Acid | 3 | 2010 | 211 | 0.160 |
Why?
|
| Genetic Association Studies | 2 | 2021 | 2703 | 0.150 |
Why?
|
| Chromosomes, Human, X | 1 | 2019 | 296 | 0.150 |
Why?
|
| Gene Expression Regulation, Fungal | 5 | 2020 | 502 | 0.150 |
Why?
|
| Methyltransferases | 1 | 2020 | 367 | 0.150 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2021 | 1692 | 0.150 |
Why?
|
| BRCA1 Protein | 2 | 2022 | 1149 | 0.150 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2017 | 67 | 0.150 |
Why?
|
| Chromosomal Position Effects | 1 | 2017 | 12 | 0.150 |
Why?
|
| Hydrocephalus | 1 | 2023 | 748 | 0.150 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2017 | 73 | 0.150 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 3 | 2015 | 1624 | 0.150 |
Why?
|
| Signal Transduction | 14 | 2021 | 23403 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2012 | 627 | 0.150 |
Why?
|
| Meningioma | 3 | 2012 | 1209 | 0.150 |
Why?
|
| Nephrons | 1 | 2018 | 220 | 0.150 |
Why?
|
| Genome, Mitochondrial | 1 | 2017 | 71 | 0.150 |
Why?
|
| Genomic Imprinting | 3 | 2017 | 328 | 0.140 |
Why?
|
| Nucleoplasmins | 1 | 2016 | 5 | 0.140 |
Why?
|
| Vascular Grafting | 1 | 2018 | 142 | 0.140 |
Why?
|
| Alleles | 6 | 2021 | 6933 | 0.140 |
Why?
|
| Meningeal Neoplasms | 3 | 2012 | 1241 | 0.140 |
Why?
|
| Micrococcal Nuclease | 1 | 2016 | 37 | 0.140 |
Why?
|
| Insulin Resistance | 2 | 2009 | 3864 | 0.140 |
Why?
|
| Transcription Initiation Site | 3 | 2014 | 196 | 0.140 |
Why?
|
| Punctures | 1 | 2018 | 374 | 0.140 |
Why?
|
| Lung Neoplasms | 5 | 2019 | 13102 | 0.140 |
Why?
|
| Wnt Proteins | 2 | 2012 | 721 | 0.140 |
Why?
|
| RNA, Fungal | 1 | 2017 | 164 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 380 | 0.140 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2016 | 42 | 0.140 |
Why?
|
| Chromatin Assembly Factor-1 | 1 | 2015 | 20 | 0.140 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2016 | 80 | 0.140 |
Why?
|
| Transduction, Genetic | 2 | 2016 | 913 | 0.140 |
Why?
|
| Cardiac Care Facilities | 1 | 2015 | 35 | 0.140 |
Why?
|
| Spermatogenesis | 2 | 2008 | 262 | 0.140 |
Why?
|
| Estrogens | 1 | 2023 | 1566 | 0.140 |
Why?
|
| Organogenesis | 2 | 2021 | 222 | 0.130 |
Why?
|
| CpG Islands | 4 | 2019 | 1172 | 0.130 |
Why?
|
| DNA, Satellite | 1 | 2015 | 69 | 0.130 |
Why?
|
| Leiomyomatosis | 1 | 2016 | 70 | 0.130 |
Why?
|
| Likelihood Functions | 1 | 2019 | 1005 | 0.130 |
Why?
|
| Genes, BRCA2 | 1 | 2019 | 618 | 0.130 |
Why?
|
| Microscopy, Confocal | 1 | 2021 | 1970 | 0.130 |
Why?
|
| Smooth Muscle Tumor | 1 | 2016 | 67 | 0.130 |
Why?
|
| Catheters, Indwelling | 1 | 2018 | 426 | 0.130 |
Why?
|
| Systems Integration | 2 | 2008 | 440 | 0.130 |
Why?
|
| Ribosome Subunits, Small, Eukaryotic | 1 | 2014 | 19 | 0.130 |
Why?
|
| Telomere | 2 | 2020 | 910 | 0.130 |
Why?
|
| Genes, BRCA1 | 1 | 2019 | 781 | 0.130 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2014 | 62 | 0.130 |
Why?
|
| Acids | 1 | 2015 | 127 | 0.130 |
Why?
|
| Multivariate Analysis | 3 | 2019 | 12245 | 0.130 |
Why?
|
| Carcinoma, Small Cell | 1 | 2017 | 420 | 0.120 |
Why?
|
| Haplotypes | 1 | 2021 | 2779 | 0.120 |
Why?
|
| Aging | 3 | 2024 | 8664 | 0.120 |
Why?
|
| Nuclear Lamina | 1 | 2014 | 46 | 0.120 |
Why?
|
| Rare Diseases | 1 | 2019 | 553 | 0.120 |
Why?
|
| Models, Molecular | 3 | 2017 | 5456 | 0.120 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2013 | 182 | 0.120 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 677 | 0.120 |
Why?
|
| Hospitals, Public | 1 | 2015 | 207 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2021 | 2699 | 0.120 |
Why?
|
| Vascular Neoplasms | 1 | 2016 | 175 | 0.120 |
Why?
|
| Statistics, Nonparametric | 2 | 2015 | 2886 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 4 | 2021 | 6314 | 0.120 |
Why?
|
| Trophoblasts | 1 | 2015 | 215 | 0.120 |
Why?
|
| DNA Replication | 3 | 2017 | 1399 | 0.120 |
Why?
|
| Radiotherapy, High-Energy | 1 | 2014 | 228 | 0.120 |
Why?
|
| Genomic Library | 1 | 2014 | 193 | 0.120 |
Why?
|
| Chromosomes, Human | 2 | 2014 | 457 | 0.120 |
Why?
|
| Molecular Sequence Data | 7 | 2014 | 18111 | 0.120 |
Why?
|
| F-Box Proteins | 2 | 2013 | 197 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2019 | 1142 | 0.120 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2013 | 22 | 0.120 |
Why?
|
| Neonatal Screening | 1 | 2018 | 591 | 0.120 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 1028 | 0.120 |
Why?
|
| Evolution, Molecular | 4 | 2020 | 1940 | 0.120 |
Why?
|
| Interferon-beta | 2 | 2005 | 323 | 0.110 |
Why?
|
| Reference Standards | 1 | 2017 | 1025 | 0.110 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2015 | 243 | 0.110 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2014 | 145 | 0.110 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2013 | 78 | 0.110 |
Why?
|
| Microarray Analysis | 4 | 2012 | 767 | 0.110 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2013 | 124 | 0.110 |
Why?
|
| RNA Interference | 5 | 2015 | 2889 | 0.110 |
Why?
|
| Health Level Seven | 1 | 2013 | 38 | 0.110 |
Why?
|
| Species Specificity | 2 | 2014 | 2478 | 0.110 |
Why?
|
| Spermatozoa | 2 | 2008 | 625 | 0.110 |
Why?
|
| Prefrontal Cortex | 2 | 2021 | 2147 | 0.110 |
Why?
|
| Gene Expression | 6 | 2012 | 7799 | 0.110 |
Why?
|
| DNA Footprinting | 1 | 2012 | 98 | 0.110 |
Why?
|
| Genes, p53 | 1 | 2015 | 755 | 0.110 |
Why?
|
| Methylation | 5 | 2015 | 1106 | 0.110 |
Why?
|
| Insulator Elements | 1 | 2012 | 27 | 0.110 |
Why?
|
| Brain | 7 | 2023 | 26385 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2017 | 2109 | 0.110 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2013 | 611 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 2 | 2017 | 2635 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 2 | 2013 | 873 | 0.110 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2013 | 131 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2021 | 1199 | 0.110 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2012 | 129 | 0.110 |
Why?
|
| Heterozygote | 1 | 2019 | 2804 | 0.100 |
Why?
|
| Citric Acid Cycle | 1 | 2013 | 232 | 0.100 |
Why?
|
| Myositis | 2 | 2005 | 251 | 0.100 |
Why?
|
| Cicatrix | 1 | 2018 | 764 | 0.100 |
Why?
|
| Karyotyping | 3 | 2012 | 1243 | 0.100 |
Why?
|
| Multiprotein Complexes | 5 | 2017 | 1119 | 0.100 |
Why?
|
| K562 Cells | 2 | 2016 | 634 | 0.100 |
Why?
|
| Sensitivity and Specificity | 6 | 2015 | 14722 | 0.100 |
Why?
|
| Phosphatidate Phosphatase | 1 | 2011 | 21 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2012 | 4751 | 0.100 |
Why?
|
| Frameshift Mutation | 1 | 2013 | 399 | 0.100 |
Why?
|
| Genes | 1 | 2015 | 1893 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 1 | 2019 | 1351 | 0.100 |
Why?
|
| Terminator Regions, Genetic | 1 | 2011 | 28 | 0.100 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2011 | 90 | 0.100 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2012 | 177 | 0.100 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2015 | 806 | 0.100 |
Why?
|
| Chondrosarcoma | 1 | 2014 | 309 | 0.100 |
Why?
|
| Medical Record Linkage | 1 | 2013 | 284 | 0.100 |
Why?
|
| Labor Unions | 1 | 2011 | 47 | 0.100 |
Why?
|
| Caudate Nucleus | 1 | 2012 | 393 | 0.100 |
Why?
|
| Retina | 2 | 2021 | 2616 | 0.100 |
Why?
|
| Tauopathies | 1 | 2014 | 307 | 0.100 |
Why?
|
| Interferon-alpha | 2 | 2005 | 895 | 0.100 |
Why?
|
| Rhabdomyolysis | 1 | 2012 | 150 | 0.100 |
Why?
|
| Mental Disorders | 2 | 2023 | 6600 | 0.090 |
Why?
|
| Chromosomal Instability | 1 | 2012 | 184 | 0.090 |
Why?
|
| Gene Silencing | 5 | 2017 | 1538 | 0.090 |
Why?
|
| Primates | 1 | 2013 | 545 | 0.090 |
Why?
|
| Health Status Indicators | 1 | 2016 | 969 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 3616 | 0.090 |
Why?
|
| Calcium | 1 | 2024 | 5756 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2020 | 9239 | 0.090 |
Why?
|
| Middle Aged | 21 | 2023 | 213383 | 0.090 |
Why?
|
| Proteins | 5 | 2023 | 6103 | 0.090 |
Why?
|
| Chordoma | 1 | 2014 | 359 | 0.090 |
Why?
|
| Information Systems | 1 | 2013 | 410 | 0.090 |
Why?
|
| Lower Extremity | 1 | 2018 | 1158 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2018 | 2453 | 0.090 |
Why?
|
| Tooth | 1 | 2012 | 207 | 0.090 |
Why?
|
| RNA, Neoplasm | 1 | 2013 | 769 | 0.090 |
Why?
|
| Molecular Imaging | 1 | 2017 | 828 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 1364 | 0.090 |
Why?
|
| Mammals | 2 | 2014 | 1143 | 0.090 |
Why?
|
| Cell Cycle Proteins | 2 | 2019 | 3462 | 0.090 |
Why?
|
| Acute Kidney Injury | 2 | 2013 | 1972 | 0.090 |
Why?
|
| Language | 1 | 2019 | 1471 | 0.090 |
Why?
|
| Aneuploidy | 1 | 2013 | 530 | 0.090 |
Why?
|
| Receptors, Virus | 1 | 2013 | 648 | 0.090 |
Why?
|
| Oligonucleotide Probes | 1 | 2010 | 427 | 0.090 |
Why?
|
| Gene Library | 2 | 2011 | 1074 | 0.090 |
Why?
|
| Skull Base Neoplasms | 1 | 2014 | 284 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2003 | 4034 | 0.090 |
Why?
|
| Kinetochores | 1 | 2011 | 194 | 0.090 |
Why?
|
| Lens, Crystalline | 1 | 2012 | 388 | 0.090 |
Why?
|
| Clone Cells | 3 | 2021 | 1692 | 0.090 |
Why?
|
| Pain Measurement | 1 | 2020 | 3420 | 0.090 |
Why?
|
| Blotting, Western | 6 | 2014 | 5179 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2010 | 2038 | 0.090 |
Why?
|
| Tooth, Supernumerary | 1 | 2009 | 8 | 0.090 |
Why?
|
| Censuses | 1 | 2011 | 200 | 0.090 |
Why?
|
| Lipogenesis | 1 | 2011 | 212 | 0.090 |
Why?
|
| Phenotype | 5 | 2020 | 16365 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2015 | 2849 | 0.090 |
Why?
|
| Ischemia | 1 | 2018 | 1907 | 0.090 |
Why?
|
| Myocytes, Cardiac | 1 | 2018 | 1637 | 0.090 |
Why?
|
| Data Mining | 1 | 2014 | 537 | 0.090 |
Why?
|
| Statistics as Topic | 2 | 2008 | 2373 | 0.090 |
Why?
|
| Adult Stem Cells | 1 | 2011 | 216 | 0.090 |
Why?
|
| Amnion | 1 | 2010 | 209 | 0.090 |
Why?
|
| Proportional Hazards Models | 2 | 2015 | 12354 | 0.090 |
Why?
|
| Genetic Loci | 3 | 2015 | 2575 | 0.080 |
Why?
|
| Program Development | 1 | 2015 | 1316 | 0.080 |
Why?
|
| Marital Status | 1 | 2011 | 437 | 0.080 |
Why?
|
| Chromosome Deletion | 2 | 2014 | 1401 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2009 | 11725 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 2 | 2017 | 2727 | 0.080 |
Why?
|
| Pharmacoepidemiology | 1 | 2012 | 323 | 0.080 |
Why?
|
| RNA, Small Interfering | 5 | 2019 | 3505 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2013 | 1097 | 0.080 |
Why?
|
| Stem Cells | 2 | 2021 | 3567 | 0.080 |
Why?
|
| Embryonic Development | 3 | 2021 | 711 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2002 | 3444 | 0.080 |
Why?
|
| Enterocytes | 1 | 2010 | 225 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2009 | 322 | 0.080 |
Why?
|
| Risk Assessment | 5 | 2021 | 23338 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 783 | 0.080 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2012 | 469 | 0.080 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 1061 | 0.080 |
Why?
|
| Antibody Specificity | 1 | 2010 | 1095 | 0.080 |
Why?
|
| Patient Participation | 1 | 2018 | 1457 | 0.080 |
Why?
|
| Survival Analysis | 3 | 2017 | 10252 | 0.080 |
Why?
|
| Ascorbic Acid | 1 | 2012 | 651 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 5172 | 0.080 |
Why?
|
| Short Bowel Syndrome | 1 | 2012 | 345 | 0.080 |
Why?
|
| Placenta | 2 | 2015 | 1698 | 0.080 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2009 | 188 | 0.080 |
Why?
|
| Muscle, Skeletal | 3 | 2021 | 4931 | 0.080 |
Why?
|
| Reperfusion Injury | 2 | 2013 | 1026 | 0.080 |
Why?
|
| Kidney Neoplasms | 2 | 2016 | 4262 | 0.080 |
Why?
|
| Papillomaviridae | 1 | 2014 | 1119 | 0.080 |
Why?
|
| History, 19th Century | 1 | 2011 | 720 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 705 | 0.080 |
Why?
|
| Jejunum | 1 | 2010 | 480 | 0.080 |
Why?
|
| Cell Cycle | 3 | 2011 | 2967 | 0.080 |
Why?
|
| Hematopoietic System | 1 | 2008 | 109 | 0.080 |
Why?
|
| Models, Statistical | 3 | 2011 | 5102 | 0.080 |
Why?
|
| Apoptosis | 5 | 2021 | 9727 | 0.080 |
Why?
|
| Cell Division | 3 | 2021 | 4568 | 0.080 |
Why?
|
| Adult | 16 | 2023 | 214055 | 0.080 |
Why?
|
| Ribonucleoproteins | 1 | 2010 | 381 | 0.080 |
Why?
|
| DNA Helicases | 1 | 2013 | 859 | 0.080 |
Why?
|
| Meiosis | 2 | 2008 | 339 | 0.080 |
Why?
|
| Multiple Myeloma | 2 | 2018 | 5181 | 0.080 |
Why?
|
| Peripheral Arterial Disease | 1 | 2018 | 1188 | 0.080 |
Why?
|
| Triiodothyronine | 1 | 2009 | 494 | 0.080 |
Why?
|
| Histone Acetyltransferases | 1 | 2009 | 336 | 0.070 |
Why?
|
| Interferons | 2 | 2022 | 706 | 0.070 |
Why?
|
| Histone Demethylases | 1 | 2010 | 321 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2010 | 3386 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 1 | 2013 | 1602 | 0.070 |
Why?
|
| Membrane Proteins | 2 | 2016 | 7880 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 2126 | 0.070 |
Why?
|
| WT1 Proteins | 2 | 2020 | 178 | 0.070 |
Why?
|
| Neoplastic Stem Cells | 2 | 2012 | 1376 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 1375 | 0.070 |
Why?
|
| Mice, Transgenic | 6 | 2018 | 9734 | 0.070 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2016 | 1164 | 0.070 |
Why?
|
| Myositis, Inclusion Body | 2 | 2005 | 147 | 0.070 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2012 | 1086 | 0.070 |
Why?
|
| Receptor, EphA2 | 1 | 2006 | 42 | 0.070 |
Why?
|
| Kidney | 4 | 2020 | 7186 | 0.070 |
Why?
|
| Skin | 2 | 2019 | 4364 | 0.070 |
Why?
|
| Up-Regulation | 4 | 2013 | 4217 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2016 | 2455 | 0.070 |
Why?
|
| Endothelial Cells | 3 | 2017 | 3479 | 0.070 |
Why?
|
| Chromosome Positioning | 1 | 2006 | 18 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2012 | 838 | 0.070 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 1622 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2013 | 1640 | 0.070 |
Why?
|
| Receptor, erbB-2 | 1 | 2016 | 2416 | 0.070 |
Why?
|
| Heart Arrest | 1 | 2016 | 1470 | 0.070 |
Why?
|
| Retrospective Studies | 7 | 2020 | 77449 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 5535 | 0.070 |
Why?
|
| Computer Graphics | 1 | 2008 | 361 | 0.070 |
Why?
|
| Case-Control Studies | 4 | 2020 | 21746 | 0.070 |
Why?
|
| Intestine, Small | 1 | 2012 | 1241 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 1477 | 0.070 |
Why?
|
| Angiopoietin-2 | 1 | 2006 | 173 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 3 | 2019 | 1655 | 0.070 |
Why?
|
| Software Validation | 1 | 2005 | 59 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2011 | 2297 | 0.070 |
Why?
|
| Nucleic Acid Conformation | 1 | 2009 | 913 | 0.060 |
Why?
|
| Microsatellite Repeats | 2 | 2020 | 802 | 0.060 |
Why?
|
| Synapses | 1 | 2014 | 1728 | 0.060 |
Why?
|
| Acetylcholine | 1 | 2007 | 621 | 0.060 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2013 | 1632 | 0.060 |
Why?
|
| HIV | 1 | 2012 | 1604 | 0.060 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2008 | 415 | 0.060 |
Why?
|
| Y Chromosome | 1 | 2006 | 206 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2012 | 3002 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 2541 | 0.060 |
Why?
|
| Age Distribution | 1 | 2011 | 2902 | 0.060 |
Why?
|
| Testis | 1 | 2008 | 803 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1676 | 0.060 |
Why?
|
| Adolescent | 7 | 2021 | 85781 | 0.060 |
Why?
|
| Polymyositis | 1 | 2004 | 75 | 0.060 |
Why?
|
| Biopsy | 3 | 2019 | 6756 | 0.060 |
Why?
|
| Aged | 13 | 2020 | 163280 | 0.060 |
Why?
|
| Membrane Glycoproteins | 2 | 2013 | 3768 | 0.060 |
Why?
|
| Mutagenesis | 2 | 2020 | 1266 | 0.060 |
Why?
|
| High-Throughput Screening Assays | 1 | 2010 | 944 | 0.060 |
Why?
|
| Genetic Markers | 1 | 2011 | 2634 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 2208 | 0.060 |
Why?
|
| Proteomics | 2 | 2020 | 3638 | 0.060 |
Why?
|
| Antineoplastic Agents | 3 | 2019 | 13695 | 0.060 |
Why?
|
| Models, Biological | 5 | 2017 | 9583 | 0.060 |
Why?
|
| Biology | 1 | 2006 | 294 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 4851 | 0.060 |
Why?
|
| Solitary Nucleus | 1 | 2024 | 63 | 0.060 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2020 | 627 | 0.060 |
Why?
|
| Systems Biology | 1 | 2007 | 469 | 0.060 |
Why?
|
| Decidua | 1 | 2003 | 86 | 0.060 |
Why?
|
| Fatty Liver | 1 | 2009 | 727 | 0.060 |
Why?
|
| Receptors, Progesterone | 1 | 2008 | 1097 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 1678 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 2016 | 3679 | 0.050 |
Why?
|
| Pyrroles | 1 | 2009 | 1146 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2016 | 5021 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 7 | 2021 | 21827 | 0.050 |
Why?
|
| Human Genome Project | 1 | 2003 | 193 | 0.050 |
Why?
|
| Radiotherapy Dosage | 3 | 2015 | 2879 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 2916 | 0.050 |
Why?
|
| Doxorubicin | 2 | 2023 | 2234 | 0.050 |
Why?
|
| Risk | 1 | 2015 | 9687 | 0.050 |
Why?
|
| Antigens, CD | 2 | 2012 | 4026 | 0.050 |
Why?
|
| Telomerase | 2 | 2020 | 730 | 0.050 |
Why?
|
| Regeneration | 3 | 2021 | 1485 | 0.050 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2004 | 306 | 0.050 |
Why?
|
| Poly A | 2 | 2015 | 185 | 0.050 |
Why?
|
| Euchromatin | 2 | 2012 | 56 | 0.050 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2013 | 1634 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2021 | 40561 | 0.050 |
Why?
|
| Carcinoma | 1 | 2013 | 2375 | 0.050 |
Why?
|
| Life Cycle Stages | 1 | 2022 | 160 | 0.050 |
Why?
|
| Survival | 1 | 2002 | 163 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2008 | 1504 | 0.050 |
Why?
|
| Choroid Plexus | 1 | 2023 | 231 | 0.050 |
Why?
|
| Least-Squares Analysis | 1 | 2002 | 379 | 0.050 |
Why?
|
| Gastrula | 1 | 2021 | 84 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2016 | 3749 | 0.050 |
Why?
|
| Lamivudine | 1 | 2022 | 342 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2009 | 4011 | 0.050 |
Why?
|
| Germ Layers | 1 | 2021 | 73 | 0.050 |
Why?
|
| Residence Characteristics | 1 | 2011 | 2050 | 0.050 |
Why?
|
| Indoles | 1 | 2009 | 1839 | 0.050 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2010 | 1363 | 0.050 |
Why?
|
| Rats | 6 | 2013 | 24260 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2006 | 879 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 2734 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2013 | 2245 | 0.050 |
Why?
|
| High Mobility Group Proteins | 1 | 2021 | 187 | 0.050 |
Why?
|
| Young Adult | 3 | 2018 | 56430 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2021 | 14557 | 0.050 |
Why?
|
| Drug Monitoring | 2 | 2020 | 956 | 0.050 |
Why?
|
| Oligodendroglia | 1 | 2024 | 517 | 0.050 |
Why?
|
| Animals, Genetically Modified | 3 | 2012 | 1549 | 0.050 |
Why?
|
| Tissue Banks | 1 | 2021 | 184 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2017 | 1723 | 0.040 |
Why?
|
| Lipids | 1 | 2011 | 3305 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2012 | 3589 | 0.040 |
Why?
|
| Child | 6 | 2023 | 77709 | 0.040 |
Why?
|
| Maf Transcription Factors | 1 | 2019 | 3 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 6364 | 0.040 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2008 | 895 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2010 | 2899 | 0.040 |
Why?
|
| Serpins | 1 | 2021 | 247 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 194 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11524 | 0.040 |
Why?
|
| Chickens | 1 | 2021 | 865 | 0.040 |
Why?
|
| Muscle Development | 1 | 2021 | 271 | 0.040 |
Why?
|
| Rats, Wistar | 2 | 2013 | 1901 | 0.040 |
Why?
|
| Oncogene Protein v-akt | 1 | 2019 | 135 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2020 | 63114 | 0.040 |
Why?
|
| Cell Movement | 3 | 2017 | 5217 | 0.040 |
Why?
|
| Fibroblasts | 3 | 2016 | 4161 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 2015 | 6171 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2010 | 2624 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 4665 | 0.040 |
Why?
|
| X Chromosome Inactivation | 2 | 2014 | 224 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 3 | 2010 | 3846 | 0.040 |
Why?
|
| Indazoles | 1 | 2020 | 289 | 0.040 |
Why?
|
| Leptin | 1 | 2006 | 1599 | 0.040 |
Why?
|
| beta Catenin | 2 | 2016 | 1059 | 0.040 |
Why?
|
| Cockayne Syndrome | 1 | 2017 | 21 | 0.040 |
Why?
|
| Xeroderma Pigmentosum | 1 | 2017 | 31 | 0.040 |
Why?
|
| Nerve Growth Factors | 1 | 2021 | 574 | 0.040 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2008 | 1378 | 0.040 |
Why?
|
| Benchmarking | 1 | 2004 | 1042 | 0.040 |
Why?
|
| BRCA2 Protein | 1 | 2022 | 794 | 0.040 |
Why?
|
| Esophagus | 1 | 2023 | 1019 | 0.040 |
Why?
|
| Transcriptional Activation | 2 | 2014 | 1783 | 0.040 |
Why?
|
| Biometry | 1 | 2001 | 558 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2005 | 1349 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 5319 | 0.040 |
Why?
|
| Drugs, Investigational | 1 | 2019 | 214 | 0.040 |
Why?
|
| Entropy | 1 | 2018 | 209 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2017 | 2043 | 0.040 |
Why?
|
| Immunoblotting | 2 | 2010 | 1682 | 0.040 |
Why?
|
| Eye Proteins | 1 | 2021 | 646 | 0.040 |
Why?
|
| In Situ Hybridization | 2 | 2012 | 1950 | 0.040 |
Why?
|
| Parathyroid Hormone | 1 | 2024 | 1801 | 0.040 |
Why?
|
| Autopsy | 1 | 2021 | 1020 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3255 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2017 | 265 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2020 | 426 | 0.040 |
Why?
|
| Anti-HIV Agents | 1 | 2012 | 4256 | 0.040 |
Why?
|
| Dialysis | 1 | 2016 | 75 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2017 | 203 | 0.040 |
Why?
|
| Prostatic Neoplasms | 2 | 2012 | 11124 | 0.040 |
Why?
|
| Immunohistochemistry | 4 | 2014 | 11366 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 2 | 2017 | 1526 | 0.040 |
Why?
|
| Mitosis | 2 | 2015 | 1208 | 0.040 |
Why?
|
| United States | 6 | 2018 | 69872 | 0.030 |
Why?
|
| Tumor Burden | 2 | 2013 | 1915 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 809 | 0.030 |
Why?
|
| Precancerous Conditions | 1 | 2003 | 975 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2013 | 4468 | 0.030 |
Why?
|
| Pan troglodytes | 1 | 2016 | 229 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2016 | 408 | 0.030 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2021 | 615 | 0.030 |
Why?
|
| DNA Primers | 2 | 2010 | 2892 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2018 | 25625 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 7279 | 0.030 |
Why?
|
| Ovary | 1 | 2020 | 981 | 0.030 |
Why?
|
| MafB Transcription Factor | 1 | 2015 | 25 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 1838 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 2021 | 1005 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 742 | 0.030 |
Why?
|
| Cytogenetic Analysis | 1 | 2016 | 295 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 5256 | 0.030 |
Why?
|
| Leukocytosis | 1 | 2016 | 247 | 0.030 |
Why?
|
| Pupa | 1 | 2014 | 37 | 0.030 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2017 | 434 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 940 | 0.030 |
Why?
|
| Sunlight | 1 | 2016 | 325 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2003 | 2133 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2018 | 600 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2021 | 1869 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 281 | 0.030 |
Why?
|
| Cell Nucleolus | 1 | 2014 | 166 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2017 | 895 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2015 | 367 | 0.030 |
Why?
|
| Blastocyst | 1 | 2017 | 424 | 0.030 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2014 | 147 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 720 | 0.030 |
Why?
|
| Infant | 2 | 2017 | 35136 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 315 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2018 | 721 | 0.030 |
Why?
|
| Embryo, Mammalian | 2 | 2010 | 1701 | 0.030 |
Why?
|
| MyoD Protein | 1 | 2014 | 151 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 890 | 0.030 |
Why?
|
| Kenya | 1 | 2015 | 685 | 0.030 |
Why?
|
| Capacity Building | 1 | 2015 | 248 | 0.030 |
Why?
|
| GTP-Binding Proteins | 2 | 2010 | 970 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 2013 | 377 | 0.030 |
Why?
|
| Database Management Systems | 1 | 2014 | 270 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2017 | 41006 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 658 | 0.030 |
Why?
|
| Larva | 1 | 2014 | 519 | 0.030 |
Why?
|
| Virus Integration | 1 | 2014 | 299 | 0.030 |
Why?
|
| Age Factors | 3 | 2017 | 18370 | 0.030 |
Why?
|
| Dacarbazine | 1 | 2015 | 566 | 0.030 |
Why?
|
| Leukemia | 1 | 2001 | 1511 | 0.030 |
Why?
|
| Gene Duplication | 1 | 2013 | 329 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2012 | 245 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2017 | 728 | 0.030 |
Why?
|
| Goals | 1 | 2017 | 706 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2014 | 2915 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15540 | 0.030 |
Why?
|
| Mitochondria | 2 | 2018 | 3520 | 0.030 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2014 | 434 | 0.030 |
Why?
|
| Carbonic Anhydrases | 1 | 2012 | 115 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 504 | 0.030 |
Why?
|
| Piperidines | 1 | 2020 | 1602 | 0.030 |
Why?
|
| Response Elements | 1 | 2013 | 312 | 0.020 |
Why?
|
| HMGA2 Protein | 1 | 2012 | 123 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2012 | 5974 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2019 | 1058 | 0.020 |
Why?
|
| Trisomy | 1 | 2012 | 266 | 0.020 |
Why?
|
| Gentamicins | 1 | 2012 | 255 | 0.020 |
Why?
|
| Octamer Transcription Factors | 1 | 2010 | 23 | 0.020 |
Why?
|
| Genes, p16 | 1 | 2011 | 157 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2014 | 959 | 0.020 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2012 | 223 | 0.020 |
Why?
|
| Myometrium | 1 | 2012 | 181 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2016 | 1133 | 0.020 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 57776 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2011 | 352 | 0.020 |
Why?
|
| Cell Survival | 2 | 2011 | 5882 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2014 | 453 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 2170 | 0.020 |
Why?
|
| Cell Enlargement | 1 | 2010 | 61 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2013 | 551 | 0.020 |
Why?
|
| Glycoproteins | 2 | 2012 | 2263 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2023 | 53288 | 0.020 |
Why?
|
| DNA Modification Methylases | 1 | 2011 | 206 | 0.020 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2012 | 371 | 0.020 |
Why?
|
| Malformations of Cortical Development | 1 | 2012 | 200 | 0.020 |
Why?
|
| RNA, Small Untranslated | 1 | 2010 | 76 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8324 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4204 | 0.020 |
Why?
|
| Intestinal Mucosa | 2 | 2012 | 3036 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 8301 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2014 | 1539 | 0.020 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2015 | 871 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2013 | 8436 | 0.020 |
Why?
|
| Uncertainty | 1 | 2015 | 734 | 0.020 |
Why?
|
| Photoperiod | 1 | 2010 | 136 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 905 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2022 | 2987 | 0.020 |
Why?
|
| MSX1 Transcription Factor | 1 | 2009 | 53 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2016 | 2375 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 1741 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2012 | 675 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2010 | 297 | 0.020 |
Why?
|
| Vesicular Transport Proteins | 1 | 2012 | 377 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 15076 | 0.020 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2009 | 61 | 0.020 |
Why?
|
| Protein Transport | 1 | 2015 | 1988 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2014 | 817 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2017 | 1099 | 0.020 |
Why?
|
| DNA Repair Enzymes | 1 | 2011 | 349 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 6622 | 0.020 |
Why?
|
| G1 Phase | 1 | 2010 | 415 | 0.020 |
Why?
|
| Obesity | 1 | 2011 | 12745 | 0.020 |
Why?
|
| Pregnancy | 3 | 2021 | 29144 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 1114 | 0.020 |
Why?
|
| RNA Probes | 1 | 2008 | 113 | 0.020 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2009 | 188 | 0.020 |
Why?
|
| Radiometry | 1 | 2014 | 800 | 0.020 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2008 | 98 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2013 | 970 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2012 | 1792 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2010 | 462 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 300 | 0.020 |
Why?
|
| Casein Kinase II | 1 | 2008 | 128 | 0.020 |
Why?
|
| Receptors, Immunologic | 2 | 2005 | 1423 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 1866 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2010 | 684 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2018 | 1880 | 0.020 |
Why?
|
| Cyclins | 1 | 2010 | 603 | 0.020 |
Why?
|
| Child Development | 1 | 2019 | 2223 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2010 | 322 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2005 | 10180 | 0.020 |
Why?
|
| Receptors, Leptin | 1 | 2009 | 360 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 3586 | 0.020 |
Why?
|
| Iodide Peroxidase | 1 | 2009 | 293 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 1613 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2013 | 2716 | 0.020 |
Why?
|
| Family | 1 | 2018 | 3147 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2008 | 1157 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 1081 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2008 | 351 | 0.020 |
Why?
|
| Seizures | 1 | 2019 | 2859 | 0.020 |
Why?
|
| Risk Factors | 3 | 2018 | 72290 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2008 | 500 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2009 | 730 | 0.020 |
Why?
|
| Spermatids | 1 | 2006 | 36 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 6993 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 546 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2007 | 242 | 0.020 |
Why?
|
| GTPase-Activating Proteins | 1 | 2010 | 498 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2010 | 538 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 4479 | 0.020 |
Why?
|
| Microvessels | 1 | 2010 | 544 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2010 | 934 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2007 | 862 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2008 | 698 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2010 | 704 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2006 | 399 | 0.020 |
Why?
|
| Time Factors | 2 | 2018 | 40075 | 0.020 |
Why?
|
| Cataract | 1 | 2012 | 834 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 2085 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2012 | 1405 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2010 | 2839 | 0.020 |
Why?
|
| Critical Illness | 1 | 2018 | 2670 | 0.020 |
Why?
|
| Obesity, Morbid | 1 | 2016 | 1213 | 0.020 |
Why?
|
| Macrophages | 1 | 2020 | 5655 | 0.020 |
Why?
|
| Uterus | 1 | 2009 | 711 | 0.020 |
Why?
|
| Epigenomics | 1 | 2010 | 903 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2009 | 822 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2005 | 319 | 0.020 |
Why?
|
| Hippocampus | 1 | 2017 | 3675 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 1434 | 0.020 |
Why?
|
| Heart Rate | 1 | 2016 | 4091 | 0.020 |
Why?
|
| tau Proteins | 1 | 2014 | 1868 | 0.020 |
Why?
|
| Nerve Net | 1 | 2017 | 2174 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2018 | 3209 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 7181 | 0.020 |
Why?
|
| Random Allocation | 1 | 2009 | 2429 | 0.020 |
Why?
|
| Liver | 2 | 2011 | 7474 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 8949 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 3701 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 8037 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6538 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2019 | 6150 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2010 | 2025 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2012 | 1988 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2008 | 1526 | 0.010 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily C | 1 | 2003 | 32 | 0.010 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2010 | 852 | 0.010 |
Why?
|
| Transgenes | 1 | 2007 | 1009 | 0.010 |
Why?
|
| Receptors, Natural Killer Cell | 1 | 2003 | 57 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 1791 | 0.010 |
Why?
|
| Computers, Molecular | 1 | 2003 | 14 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 2203 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 7729 | 0.010 |
Why?
|
| Phylogeny | 1 | 2010 | 2803 | 0.010 |
Why?
|
| Genes, cdc | 1 | 2003 | 116 | 0.010 |
Why?
|
| Autophagy | 1 | 2010 | 1300 | 0.010 |
Why?
|
| Postoperative Complications | 2 | 2018 | 15295 | 0.010 |
Why?
|
| Galectin 1 | 1 | 2003 | 131 | 0.010 |
Why?
|
| Pregnancy Proteins | 1 | 2003 | 229 | 0.010 |
Why?
|
| Neuromuscular Diseases | 1 | 2005 | 248 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2013 | 3086 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2016 | 5317 | 0.010 |
Why?
|
| Antibodies | 1 | 2010 | 2460 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2016 | 3114 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 1889 | 0.010 |
Why?
|
| Transfection | 1 | 2010 | 5892 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 2005 | 588 | 0.010 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2005 | 555 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 2382 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12788 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2006 | 1285 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 7913 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 18029 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2003 | 1101 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 2010 | 2072 | 0.010 |
Why?
|
| Prevalence | 1 | 2017 | 15226 | 0.010 |
Why?
|
| Genes, Fungal | 1 | 2002 | 455 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2010 | 2948 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2008 | 2513 | 0.010 |
Why?
|
| Peptides | 1 | 2012 | 4409 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2008 | 2187 | 0.010 |
Why?
|
| Homeostasis | 1 | 2010 | 3340 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2010 | 2728 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29063 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2008 | 2564 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 3870 | 0.010 |
Why?
|
| Blood Vessels | 1 | 2005 | 1125 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 13815 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 5751 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 4386 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 3772 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 8642 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 9274 | 0.010 |
Why?
|
| Sirolimus | 1 | 2002 | 1564 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2005 | 2725 | 0.010 |
Why?
|
| Lung | 1 | 2011 | 9856 | 0.010 |
Why?
|
| Insulin | 1 | 2007 | 6580 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20129 | 0.010 |
Why?
|
| Sex Factors | 1 | 2003 | 10397 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2002 | 4149 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2002 | 11031 | 0.000 |
Why?
|